When: March 26, 2026
Where: QNC 1501
Advances in molecular sensing and lab-on-a-chip technology
Abstract :
In this seminar, Martin Bennink wants to present to you some of the activities and developments in molecular sensing as well as lab- and organ-on-chip. This includes :
- (i) the use of integrated photonics chip sensors for measuring concentration of biological biomarkers such as insulin, for persons to manage progression towards diabetes type 2.
- (ii) Lateral flow assays and lab-on-a-chip for analysis of forensic samples to provide intelligence on the crime scene on the persons involved in a crime.
- (iii) Development of a heart-on-a-chip screening platform for investigating the triggers of atrial fibrillation. (iv) Development of a lab-on-a-chip device to produce lipid nanoparticles as drug delivery vehicles in the treatment of orphan diseases.
Biography
Martin Bennink (1973) has studied Applied Physics and done his PhD in the field of single-molecule biophysics at the University of Twente. After this, he worked for a number of years as a research program coordinator at the MESA+ Institute for Nanotechnology, and was later appointed as an assistant professor in Nanobiophysics at the University of Twente
In his current position as Professor of Applied Nanotechnology at Saxion University of Applied Sciences in Enschede and Deventer, the Netherlands, he is chairing a research group that is setting up application-driven, multidisciplinary research projects at the interface of nanotechnology and life sciences. These projects are in very close collaboration with industry, SMEs and other societal partners, aimed at different societal challenges, in the areas of health, wellbeing, security and environmental stewardship.
Current research lines are:
- (i) molecular sensing technologies
- (ii) lab-on-a-chip / organ-on-a-chip
- (iii) nanostructured surfaces and nanomaterials and (iv) societal embedding of nanotechnology.